Evidence map›Paper›PMID 42204305›Full record

ArticleEMBO molecular medicine2026

Mitochondrial activity promotes neutrophil degranulation and endothelial dysfunction in systemic infections.

Przemysław Zakrzewski, Christopher M Rice, Claire Naveh, Isaac Dowell, Kathryn Fleming, Aravind V Ramesh, Rachel Jones, Pedro L Moura, Drinalda Cela, Sarah Groves and 18 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Przemysław Zakrzewski *School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.
Christopher M Rice *School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.
Claire Naveh *School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.ORCID 0009-0004-5953-5111
Isaac DowellSchool of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.
Kathryn FlemingSchool of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.
Aravind V RameshBristol Veterinary School, University of Bristol, Bristol, UK.ORCID 0000-0001-8302-7097
Rachel JonesSchool of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.ORCID 0009-0001-2935-7586
Pedro L MouraCenter for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0002-0493-5394
Drinalda CelaSchool of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.ORCID 0009-0005-6657-7472
Sarah GrovesSchool of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.
Stephanie Fletcher-JonesSchool of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.ORCID 0009-0001-2517-6243
Yohance VictorySchool of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.ORCID 0009-0001-3820-4696
Mainga BhimaSchool of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.
Stefan EbmeierDepartment of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.ORCID 0000-0001-7570-7172
Laura CareyBristol Medical School, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.ORCID 0000-0003-4158-4527
Matthew ButlerBristol Medical School, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-9814-8008
Simon C SatchellBristol Medical School, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.
Ase BergDepartment of Medicine, Stavanger University Hospital, Stavanger, Norway.
Nadia PaloliteDepartment of Medicine, Central Hospital of Maputo, Maputo, Mozambique.
James NyirendaMalawi-Liverpool Wellcome Trust Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
Watipenge NyasuluMalawi-Liverpool Wellcome Trust Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
Isabel ZgamboMalawi-Liverpool Wellcome Trust Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
Charalampos AttipaSchool of Infection and Immunity, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Linda WooldridgeBristol Veterinary School, University of Bristol, Bristol, UK.
Andrew D DavidsonSchool of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK.
Aubrey CunningtonDepartment of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.
Christopher A Moxon *Malawi-Liverpool Wellcome Trust Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.ORCID 0000-0001-6087-9393
Borko Amulic *School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK. borko.amulic@bristol.ac.uk.ORCID 0000-0002-8518-8393

Funding

Alex and Eva Wallström Foundation Dnr 2024-00311Dr. Ake Olsson Foundation Dnr 2024-00303KI Research Foundation Dnr 2024-02330Myelodysplastic Syndromes Foundation, Inc 1142079UKRI | Medical Research Council (MRC) MR/R02149X/1UKRI | Medical Research Council (MRC) MR/V025856/1Wellcome TrustWellcome Trust (WT) 225540/Z/22/Z
6 · The paper itself

Abstract

Neutrophils are essential for defense against pathogens but excessive activation in systemic infections can drive immunopathology. We show that neutrophil degranulation can induce endothelial dysfunction via degradation of the glycocalyx and increase of endothelial permeability. To identify targetable pathways regulating neutrophil degranulation in severe inflammation, we compared the proteomes of neutrophils isolated from patients with severe malaria and sepsis. We found significant upregulation of mitochondrial pathways, which was accompanied by increased rates of mitochondrial respiration and was linked to neutrophil immaturity. Malaria induced mitochondrial fusion and networking, while sepsis was associated with mitochondrial biogenesis. Immature neutrophils in both infections produced elevated levels of mitochondrial ROS, which enhanced release of primary and secondary granules via reorganization of cortical actin. Our study provides a mechanistic explanation for the hyperinflammatory nature of immature neutrophils and points to pharmacological scavenging of mitochondrial ROS as a potential therapeutic strategy to reduce endothelial damage in severe inflammation.

Indexed as

Cell DegranulationEndothelial CellsMalariaMitochondriaNeutrophilsSepsisHumansProteomeReactive Oxygen SpeciesProteomeReactive Oxygen Species

Identifiers

PMID42204305
PMCPMC13365472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.